| AUC | area under the curve |
| BCBM | breast cancer brain metastasis |
| CA19-9 | cancer antigen 19-9 |
| CEA | carcinoembryonic antigen |
| CI | confidence interval |
| CTC | circulating tumor cell |
| CTM | circulating tumor microembolies |
| DC | disease control |
| CA19-9 | cancer antigen 19-9 |
| CEA | carcinoembryonic antigen |
| CI | confidence interval |
| CTC | circulating tumor cell |
| CTM | circulating tumor microembolies |
| DC | disease control |
| DFS | disease-free survival |
| ECM | extracellular matrix |
| EMT | epithelial to mesenchymal transition |
| EpCAM | epithelial cell adhesion molecule |
| GC | gastric cancer |
| IHC | immunohistochemistry |
| HR | hazard ratio |
| MET | mesenchymal to epithelial cell transition |
| MHC | major histocompatibility complex |
| MP1-MMP | membrane type 1 matrix metalloproteinase |
| OS | overall survival |
| ROC | receiver operating characteristic |
| WBC | white blood cell |